Agilent Technologies (A) EBT Margin Growth (3y) (2013 - 2026)
Analysis
Agilent Technologies (A) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -211.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1,575.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3,000.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -138.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -730.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 30,357.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -871.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 2,904.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -1,462.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1,575.00 |
| Apr 30, 2026 | 28.00 |
| Jan 31, 2026 | -310.00 |
| Oct 31, 2025 | -86.00 |
| Jul 31, 2025 | -205.00 |
| Apr 30, 2025 | -513.00 |
| Jan 31, 2025 | 278.00 |
| Oct 31, 2024 | -341.00 |
| Jul 31, 2024 | 112.00 |
| Apr 30, 2024 | 587.00 |
| Jan 31, 2024 | 415.00 |
| Oct 31, 2023 | 580.00 |
| Jul 31, 2023 | -947.00 |
| Apr 30, 2023 | 1,218.00 |
| Jan 31, 2023 | 721.00 |
| Oct 31, 2022 | 771.00 |
| Jul 31, 2022 | 568.00 |
| Apr 30, 2022 | 311.00 |
| Jan 31, 2022 | -26.00 |
| Oct 31, 2021 | 813.00 |